Author:
Nielsen Steen,Mellemkjær S.,Rasmussen L. M.,Ledet T.,Olsen N.,Bojsen-Møller M.,Astrup J.,Weeke J.,Jørgensen J. O. L.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference27 articles.
1. Katznelson L., Oppenheim D.S., Coughlin J.F., Kliman B., Schoenfeld D.A., Klibanski A. Chronic somatostatin analog administration in patients with alpha-subunit-secreting pituitary tumors. J. Clin. Endocrinol. Metab. 1992, 75: 1318–1325.
2. Broson Chazot F., Houzard C., Ajzenberg C., Nocaudie M., Duet M., Mundler O., Marchandise X., Epelbaum J., Gomez De Alzaga M., Schafer J., Meyerhof W., Sassolas G., Warnet A. Somatostatin receptor imaging in somatotroph and non-functioning pituitary adenomas: correlation with hormonal and visual responses to octreotide. Clin. Endocrinol. Oxf. 1997, 47: 589–598.
3. Kubota A., Yamada Y., Kagimoto S., Shimatsu A., Imamura M., Tsuda K., Imura H., Seino S., Seino Y. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201–995 in treatment of human endocrine tumors. J. Clin. Invest. 1994, 93: 1321–1325.
4. Plockinger U., Reichel M., Fett U., Saeger W., Quabbe H.J. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy. J. Clin. Endocrinol. Metab. 1994, 79: 1416–1423.
5. Rieger A., Rainov N.G., Elfrich C., Klaua M., Meyer H., Lautenschlager C., Burkert W., Mende T. Somatostatin receptor scintigraphy in patients with pituitary adenoma Somatostatin receptor scintigra-phy in patients with pituitary adenoma. Neurosurg. Rev. 1997, 20: 7–12.
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献